Diet and wearable monitoring of gut movement in children with IBS
Official title: The Role of Diet and Gastrointestinal Motility in Irritable Bowel Syndrome (IBS)
Run by Children's Hospital of Philadelphia · NCT07283341 · Data updated 2026-11-12
This project will use a wearable patch, diet recall, and stool and urine samples to see if certain foods, gut movement patterns, or microbes are linked to symptoms in children ages 8–18 with IBS.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 8 Years to 18 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | Children's Hospital of Philadelphia Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Status | Recruiting |
| Started | July 31, 2023 |
| Main results expected | June 2027 |
| Study ends | June 2027 |
| Registry record updated | December 15, 2025 |
| Trial ID | NCT07283341 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children 8–18 years old diagnosed with IBS whose parent/guardian can consent and who can tolerate a wearable adhesive patch and sample collection are ideal candidates.
✕Probably not a fit
Children with adhesive allergies, recent antibiotic use, inflammatory gastrointestinal disease, or inability to follow study procedures are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational study enrolling children aged 8–18 with IBS and age-matched controls without abdominal pain. Participants will wear a wireless patch to record gut motility, complete questionnaires and a 24-hour dietary recall, and provide stool and urine samples for microbiome and metabolite analysis. Investigators will compare dietary patterns, motility signals, and microbial/metabolic profiles between children with and without IBS symptoms to identify links. Findings aim to help tailor diet-based approaches to relieve symptoms in pediatric IBS.
Why it matters
Potential benefit: If successful, the study could enable more personalized diet plans or monitoring strategies that reduce symptoms for children with IBS.
How similar studies have gone: Related research using wearable motility monitors and microbiome-diet analyses has shown promising associations, but pediatric personalized diet strategies remain largely unproven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Cases: 1. Males and females age 8 - 18 years 2. Diagnosis of irritable bowel syndrome (IBS). 3. Parental/guardian permission (informed consent) and child assent Controls: 1. Males and Females age 8-18 years 2. No diagnosis of abdominal pain disorder 3. Parental/guardian permission (informed consent) and child assent Exclusion Criteria: Cases: 1. Allergy to adhesives 2. Inability to cooperate with study design 3. Antibiotic intake in the past 4 weeks 4. Inflammatory gastrointestinal disorder diagnosis Controls: 1. Allergy to adhesives 2. Inability to cooperate with study design 3. Antibiotic intake in the past 4 weeks 4. Inflammatory gastrointestinal disorder diagnosis
Where it's running
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Alain Benitez, MD, MSTR — Children's Hospital of Philadelphia, University of Pennsylvania
- Study coordinator: Alain Benitez, MD, MSTR
- Email: BenitezA@chop.edu
- Phone: 215-590-1000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Vitamin D Supplementation in Children with Irritable Bowel Syndrome
This study tests whether giving vitamin D to children with IBS and low vitamin D levels can improve their IBS symptoms compared with a placebo.
-
IBS-oriented Crohn's Disease Exclusion Diet versus Low FODMAP Diet for IBS
This study tests whether an IBS-adapted Crohn's Disease Exclusion Diet (CDED) can better help adults with IBS-D or IBS-M than the low FODMAP diet.
-
How certain FODMAPs affect IBS pain in adults
This study tests whether adding back specific FODMAP types after a low-FODMAP diet can reveal which ones drive abdominal pain in adults with IBS.
-
Gut–brain gut study in IBS with anxiety and depression
This study will compare people with IBS and mood symptoms to healthy volunteers to see if gut bacteria relate to brain function using questionnaires, stool and blood samples, and a brain MRI.
-
Pregabalin for irritable bowel syndrome in adults
A clinician-led study will test whether pregabalin helps adults with irritable bowel syndrome who meet specific symptom criteria.
-
Probiotic combination for irritable bowel syndrome
This trial will test whether a daily probiotic capsule lowers symptom severity and affects gut transit time in adults with IBS.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.